Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34402669.
- Also identified by DOI 10.1148/radiol.2021211374 and PMC identifier 8488809.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vaccination is one of the several known triggers of Parsonage-Turner syndrome (PTS). This case series describes two individuals with clinical presentations of PTS whose symptoms began 13 hours and 18 days following receipt of the Pfizer-BioNTech BNT162b2 and Moderna mRNA-1273 COVID-19 vaccine, respectively. The diagnosis of PTS was confirmed by using both electrodiagnostic testing and 3.0-T MR neurography. Although research is needed to understand the association between PTS and COVID-19 vaccination, MR neurography may be used to help confirm suspected cases of PTS as COVID-19 vaccines continue to be distributed worldwide.
Medical subject headings
- Brachial Plexus
- Brachial Plexus Neuritis
- COVID-19 Vaccines
- Magnetic Resonance Imaging